Access to anti-retroviral drugs, male in Slovenia

Slovenia: Access to anti-retroviral drugs, male was 87.0% in 2024. ▲ Rising

Latest (2024)
87.0%
Change on year
up 2.4%
World rank
27th
of 141 countries
All-time high
87.0%
in 2024
All-time low
28.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Slovenia, 2000–2024

204060802000201220242000: 28 %2001: 31 %2002: 34 %2003: 36 %2004: 38 %2005: 40 %2006: 55 %2007: 52 %2008: 47 %2009: 47 %2010: 62 %2011: 62 %2012: 62 %2013: 67 %2014: 71 %2015: 75 %2016: 80 %2017: 83 %2018: 84 %2019: 82 %2020: 86 %2021: 84 %2022: 84 %2023: 85 %2024: 87 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Slovenia is 87.0%, measured in 2024. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 2.4% on the previous year and up 22.5% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Slovenia peaked at 87.0% in 2024 and was at its lowest, 28.0%, in 2000.

That places Slovenia 27th out of 141 countries with data for 2024, putting it in the top quarter.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Slovenia, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Slovenia, 2000 to 2024.
Year % Change
2000 28.0%
2001 31.0% +10.7%
2002 34.0% +9.7%
2003 36.0% +5.9%
2004 38.0% +5.6%
2005 40.0% +5.3%
2006 55.0% +37.5%
2007 52.0% -5.5%
2008 47.0% -9.6%
2009 47.0% +0.0%
2010 62.0% +31.9%
2011 62.0% +0.0%
2012 62.0% +0.0%
2013 67.0% +8.1%
2014 71.0% +6.0%
2015 75.0% +5.6%
2016 80.0% +6.7%
2017 83.0% +3.8%
2018 84.0% +1.2%
2019 82.0% -2.4%
2020 86.0% +4.9%
2021 84.0% -2.3%
2022 84.0% +0.0%
2023 85.0% +1.2%
2024 87.0% +2.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 40.8% 28.0% 55.0% 10
2010s 72.8% 62.0% 84.0% 10
2020s 85.2% 84.0% 87.0% 5

Countries ranked near Slovenia

  1. 27 Ecuador 87.0% compare
  2. 27 Haiti 87.0% compare
  3. 30 Liberia 86.0% compare
  4. 30 Singapore 86.0% compare
  5. 30 Thailand 86.0% compare
  6. 30 Togo 86.0% compare

See the full ranking of 160 places →

More gender data for Slovenia

All data for Slovenia →

Frequently asked questions

What is access to anti-retroviral drugs, male in Slovenia?
Access to anti-retroviral drugs, male in Slovenia was 87.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Slovenia?
The highest recorded value was 87.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Slovenia?
The lowest recorded value was 28.0% in 2000.
How does Slovenia rank for access to anti-retroviral drugs, male?
Slovenia ranks 27th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Slovenia?
Over the last ten years it is up 22.5%. The long-run trend across the full record is rising.
Where does this Slovenia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Slovenia. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/slovenia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/slovenia/">Access to anti-retroviral drugs, male in Slovenia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.